Solid forms of cerdulatinib
US10865198B2 · kind B2 · utility
3Cited by
13References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2019 |
| Grant date | Dec 15, 2020 |
| Priority date | — |
| Expiry date | May 3, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.